1. Home
  2. CORT

CORT

Corcept Therapeutics Incorporated

Logo Corcept Therapeutics Incorporated

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Founded: 1998 Country:
United States
United States
Employees: N/A City: MENLO PARK
Market Cap: 2.5B IPO Year: N/A
Target Price: $33.60 AVG Volume (30 days): 1.4M
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.94 EPS Growth: 8.05
52 Week Low/High: $20.87 - $34.28 Next Earning Date: 05-01-2024
Revenue: $482,375,000 Revenue Growth: 20.04%
Revenue Growth (this year): 29.12% Revenue Growth (next year): 9.03%

Share on Social Networks: